Parkinson Disease: all 4,583 studies
Page 34 of 46. Open to participants first (1,097), then studies with results posted, then the rest; newest registration first within each.
- Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-BIA 9-1067CompletedNCT03119194Phase 1
- Effect of Food on OpicaponeCompletedNCT03116308Phase 1
- Bioavailability and Bioequivalence Study of Two Different Sources of OpicaponeCompletedNCT03116295Phase 1
- Effect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's DiseaseCompletedNCT03111485Phase 4
- Development and Evaluation of a Guide to Help People With Parkinson's and Their Caregivers to Self-manage FallingStatus unknownNCT03111472Not applicable
- Phenomenological and Psychopathological Factors Associated to Hallucinations in Parkinson's DiseaseTerminatedNCT03105401
- Pilot Study on the Effects of Neuromuscular Taping in Parkinson's Disease PatientsCompletedNCT03104049Not applicable
- Efficacy and Tolerability of Nebicapone in Parkinson's Disease Patients With "Wearingoff" PhenomenonCompletedNCT03103399Phase 2
- Quantification of Beta Activity in Routine EEG Recordings in Parkinson's Disease PatientsCompletedNCT03103347
- Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders:Active, not recruitingNCT03100474
- Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mgCompletedNCT03097211Phase 1
- Volumetric Bone Mineral Density and it's Relationship With Osteoporotic Fractures in Parkinson's DiseaseCompletedNCT03095690Not applicable
- Pharmacokinetic Profile of BIA 6-512 in Healthy Elderly Subjects Versus Healthy Young SubjectsCompletedNCT03095105Phase 1
- Effect of Food on BIA 6-512 (Trans-resveratrol)CompletedNCT03095092Phase 1
- Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's PhenomenonCompletedNCT03094910Not applicable
- Effect of BIA 6-512 at Steady-state on the Levodopa PharmacokineticsCompletedNCT03094156Phase 1
- Tolerability and Steady-state Pharmacokinetics of BIA 6-512CompletedNCT03093389Phase 1
- Pharmacokinetics of Rising Single-doses of BIA 6-512 and Their Effect on the Levodopa PharmacokineticsCompletedNCT03091868Phase 1
- Tolerability, Safety and Pharmacokinetics of Four Single-doses of BIA 6-512 (Trans-resveratrol) and Their Effect on the Levodopa PharmacokineticsCompletedNCT03091543Phase 1
- Electrophysiological Recordings of Deep Brain Stimulation in the Basal GangliaCompletedNCT03088592Not applicable
- Data-Driven Characterization of Neuronal Markers During Deep Brain Stimulation for Patients With Parkinson's DiseaseStatus unknownNCT03079960Not applicable
- Proprioception and MeditationCompletedNCT03079817Not applicable
- Spinal Cord Stimulation for Gait in Parkinson DiseaseStatus unknownNCT03079310Not applicable
- Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Project 1 Aim 2 and 3CompletedNCT03079037
- More Than a Movement Disorder: Applying Palliative Care to Parkinson's DiseaseCompletedNCT03076671Not applicable
- DAT SPECT and Procedural Motor Skills in Parkinson's DiseaseCompletedNCT03076307Not applicable
- Exploring Mechanisms for Neuropsychiatric Symptoms of Parkinson Disease Using Transcranial Direct Current StimulationSuspendedNCT03074812Not applicable
- Effectiveness and Reliability of Hypnosis in StereotaxyStatus unknownNCT03074422Not applicable
- Translation and Validation of BELA-p-K for QoL Evaluation in PD PatientsCompletedNCT03073044
- Trial of OnabotulinumtoxinA for Depression in Parkinson DiseaseTerminatedNCT03069911Phase 1
- Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's DiseaseCompletedNCT03068481Phase 1
- Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's DiseaseCompletedNCT03065192Phase 1
- Investigating Therapies for Freezing of GaitStatus unknownNCT03065127Not applicable
- Exploration of the Mechanism of Movement Improvement During RBD in Parkinson's Disease Using NIRSCompletedNCT03060239Not applicable
- rTMS in Facilitation of Working Memory in PDStatus unknownNCT03059212Not applicable
- Transcutaneous Electric Nerve Stimulation in Sleep of Patients With Parkinson's DiseaseCompletedNCT03053752Not applicable
- Evaluate the Effectiveness and Safety of Variable Frequency Stimulation Compared With Constant Frequency Stimulation for Patients With Idiopathic Parkinson's DiseaseStatus unknownNCT03053726Not applicable
- Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological PathologiesTerminatedNCT03052712Not applicable
- Evolution of RBD in PDStatus unknownNCT03047408Not applicable
- Post-Physical Therapy Extension of In-Home Dynamic Standing Table Use in Parkinson DiseaseCompletedNCT03045211Not applicable
- Cutaneous Autonomic Pilomotor Testing to Unveil the Role of Neuropathy Progression in Early Parkinson's DiseaseCompletedNCT03043768
- 18F-DOPA PET Imaging: an Evaluation of Biodistribution and SafetyCompletedNCT03042416Phase 3
- Computerized Cognitive Behavioral Therapy Trial for Insomnia in Parkinson DiseaseCompletedNCT03041389Not applicable
- Measuring Parkinson's Disease With Tear FluidCompletedNCT03037463
- A Randomized, Double-Blind, Placebo-Controlled Study of Droxidopa for Fatigue in Parkinson's DiseaseTerminatedNCT03034564Phase 4
- An Open-Label Tolerability and Exploratory Efficacy Study of Zonisamide for Dyskinesias in Parkinson's DiseaseSuspendedNCT03034538Phase 4
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Infusions of ABBV-951 in Subjects With Parkinson's DiseaseCompletedNCT03033498Phase 1
- ADDIA Proof-of-Performance Clinical StudyCompletedNCT03030586
- Clinical and Physiological Studies of Tremor SyndromesCompletedNCT03027310
- The Profile of the Depression and it's Intervention Strategy in Patients With Parkinson's Disease in ChinaStatus unknownNCT03026595
- Characterization of Fecal Microbiome Changes After Administration of PRIM-DJ2727 in Parkinson's Disease PatientsWithdrawnNCT03026231Phase 1/2
- Nigrosomal Iron Imaging in Parkinson's DiseaseStatus unknownNCT03022357
- Comparing the Therapeutic Efficacy and Safety of DA-9701 With Domperidone in Patients With Parkinson's DiseaseCompletedNCT03022201Phase 4
- Effectiveness of Different Approaches for the Rehabilitation of Gait in Patients With Parkinson's DiseaseStatus unknownNCT03021408Not applicable
- Aquatic Therapy for Freezing of Gait in Parkinson's Disease PatientsCompletedNCT03015714Not applicable
- Bio Electro Stimulation Therapy for Parkinson's DiseaseCompletedNCT03014050Early Phase 1
- Tailored Music Therapy for DementiaCompletedNCT03011723Not applicable
- Effect of Acetylcholinesterase Inhibitors on the Gait of the Patients With Parkinson DiseaseStatus unknownNCT03011476Phase 4
- Role of Deep Brain Stimulation on Social Cognition in Parkinsonian PatientsCompletedNCT03004573Not applicable
- Evaluation of Ronnie Gardiner Method in Individuals With Parkinson's DiseaseCompletedNCT02999997Not applicable
- Gait Analysis in Neurological DiseaseActive, not recruitingNCT02994719
- Effect of Robot-assisted Gait Training on Gait Automaticity in Patients With Parkinson's DiseaseCompletedNCT02993042Not applicable
- Understand FoG in PD: Behavioral Physiology and Clinical ApplicationStatus unknownNCT02987140Not applicable
- Prospective Neuroimaging Investigation of Idiopathic REM Sleep Behavior DisorderCompletedNCT02984137Not applicable
- Dexmedetomidine on Basal Ganglia Neuronal Activity in Parkinson's DiseaseStatus unknownNCT02982512Phase 4
- Neural Correlates of Cognition in Parkinson's DiseaseCompletedNCT02975193Not applicable
- Benefit From the Chin Down Maneuver in the Swallowing Performance and Self-perception of Parkinson's Disease PatientsCompletedNCT02973698Not applicable
- Safety and Tolerability Study of K0706 in Subjects With Parkinson's DiseaseCompletedNCT02970019Phase 1
- Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Parkinson DiseaseCompletedNCT02969941Not applicable
- Brain Bioenergetics in Parkinson's Disease and Response to Repeated Oral UDCA TreatmentCompletedNCT02967250Phase 1
- Strength Training and Different Subtypes of Parkinson´s DiseaseCompletedNCT02966600Not applicable
- Social Cognition and Personality Changes in Alzheimer's & Parkinson's Disease & Frontotemporal Lobar DegenerationCompletedNCT02964611
- tDCS for Treatment of Depression in Parkinson's DiseaseStatus unknownNCT02960464Not applicable
- Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]FluoroethoxybenzovesamicolStatus unknownNCT02952391
- Ambroxol in Disease Modification in Parkinson DiseaseCompletedNCT02941822Phase 2
- Effect of Continuous Apomorphine During the Night on Sleep Disorders in Insomniac Patients With Parkinson's DiseaseCompletedNCT02940912Phase 4
- Antigen Presentation and Lymphocyte Response in Parkinson's DiseaseCompletedNCT02939534
- A Study of KW-6356 in Subjects With Early Parkinson's DiseaseCompletedNCT02939391Phase 2
- Goal-oriented Intervention in Parkinson's DiseaseCompletedNCT02938819Not applicable
- Deep Brain Stimulation (DBS) for Parkinson's Disease International StudyCompletedNCT02937688
- The CloudUPDRS Smartphone Software in Parkinson's Study.Status unknownNCT02937324Not applicable
- Evaluation of Nalmefene in Impulse Control Disorders in Parkinson's Disease: A Prospective Open Label StudyStatus unknownNCT02934919Phase 2
- DBS of the MLR for Gait and Balance Disorders in PD PatientsCompletedNCT02931097Not applicable
- Study of Factors Associated With the Volumetric and Areal Bone Mineral Density and Bone Strength in Parkinson's DiseaseStatus unknownNCT02930512
- Speed of Processing Training in Patients With Parkinson's Disease and Healthy Older AdultsCompletedNCT02929758Not applicable
- Evaluate the Safety and Effectiveness of Various Frequency Stimulation for Patients With Parkinson's DiseaseStatus unknownNCT02929628Phase 2
- Impact of Non-traditional Guitar Group Instruction on Functional Movement and Well-being in Parkinson's Disease PatientsCompletedNCT02925065Not applicable
- Deep Brain Stimulation of the nbM to Treat Mild Cognitive Impairment in Parkinson's DiseaseTerminatedNCT02924194Not applicable
- GALIG Gene Expression in Parkinson's DiseaseCompletedNCT02923297Not applicable
- Piloting a Novel, Mobile Cognitive Tracking and Training Tool for Patients With Parkinson's Disease (PD)WithdrawnNCT02922530Not applicable
- Long-term Stability of LFP Recorded From the STN and the Effects of DBSCompletedNCT02915848
- Ambroxol as a Treatment for Parkinson's Disease DementiaActive, not recruitingNCT02914366Phase 2
- Subthalamotomy by ExAblate Transcranial System to Treat Motor Features of Parkinson's DiseaseCompletedNCT02912871Not applicable
- Bright Light Therapy for Non-motor Symptoms in Parkinson's DiseaseActive, not recruitingNCT02909192Not applicable
- Feasibility of Continuous Sleep Recording in Patients Undergoing Deep Brain Stimulation for Parkinson's DiseaseCompletedNCT02907723Not applicable
- Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's DiseaseCompletedNCT02906488
- Mental Practice Combined With Physical Practice to Improve the Gait Performance of People With Parkinson's DiseaseCompletedNCT02904837Not applicable
- Therapeutic Yoga to Improve Function in Parkinson's DiseaseCompletedNCT02902510Not applicable
- Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic FailureTerminatedNCT02897063Phase 1
- EMG Modules as a Novel Biomarker of Basal Ganglia Plasticity in Parkinson's DiseaseTerminatedNCT02896816Not applicable